![Conley Chee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Conley Chee
Keine laufenden Positionen mehr
Profil
Conley Chee worked as the Head-Global Portfolio Management at Novartis Pharmaceuticals from 2018 to 2021.
He then served as the Chief Business & Commercial Officer at Syros Pharmaceuticals, Inc. from 2021 to 2023.
Mr. Chee completed his undergraduate studies at the University of Alberta and obtained an MBA from the Richard Ivey School of Business.
Ehemalige bekannte Positionen von Conley Chee
| Unternehmen | Position | Ende |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 22.11.2024 |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 28.02.2021 |
Ausbildung von Conley Chee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
